•
Dec 31, 2024

Reneo Pharmaceuticals Q4 2024 Earnings Report

Expected Revenue:$NaN
Expected EPS:-$0.74
34.5% YoY
Total Revenue
$0
0
Gross Profit
-$419K
0
Cash and Equivalents
$111M
Previous year: $103M
+7.6%
Free Cash Flow
-$21.1M
Previous year: -$19.8M
+6.5%
Total Assets
$115M
Previous year: $107M
+7.0%

Reneo Pharmaceuticals

Reneo Pharmaceuticals